DrugPatentWatch Database Preview
Msd Merck Co Company Profile
What is the competitive landscape for MSD MERCK CO, and when can generic versions of MSD MERCK CO drugs launch?
MSD MERCK CO has seven approved drugs.
There are three US patents protecting MSD MERCK CO drugs.
There are one hundred and forty-two patent family members on MSD MERCK CO drugs in forty-six countries and thirty-one supplementary protection certificates in eleven countries.
Summary for Msd Merck Co
| International Patents: | 142 |
| US Patents: | 3 |
| Tradenames: | 6 |
| Ingredients: | 6 |
| NDAs: | 7 |
Drugs and US Patents for Msd Merck Co
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Msd Merck Co | ZOCOR | simvastatin | TABLET;ORAL | 019766-004 | Dec 23, 1991 | AB | RX | Yes | No | See Pricing | See Pricing | ||||
| Msd Merck Co | PIFELTRO | doravirine | TABLET;ORAL | 210806-001 | Aug 30, 2018 | RX | Yes | Yes | See Pricing | See Pricing | |||||
| Msd Merck Co | ZOCOR | simvastatin | TABLET;ORAL | 019766-005 | Jul 10, 1998 | AB | RX | Yes | Yes | See Pricing | See Pricing | ||||
| Msd Merck Co | ZOCOR | simvastatin | TABLET;ORAL | 019766-003 | Dec 23, 1991 | AB | RX | Yes | No | See Pricing | See Pricing | ||||
| Msd Merck Co | SINGULAIR | montelukast sodium | TABLET, CHEWABLE;ORAL | 020830-002 | Mar 3, 2000 | AB | RX | Yes | No | See Pricing | See Pricing | ||||
| Msd Merck Co | SINGULAIR | montelukast sodium | TABLET;ORAL | 020829-002 | Feb 20, 1998 | AB | RX | Yes | Yes | See Pricing | See Pricing | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Msd Merck Co
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Msd Merck Co | ZOCOR | simvastatin | TABLET;ORAL | 019766-001 | Dec 23, 1991 | 4,444,784*PED | See Pricing |
| Msd Merck Co | ZOCOR | simvastatin | TABLET;ORAL | 019766-005 | Jul 10, 1998 | 4,444,784*PED | See Pricing |
| Msd Merck Co | ZOCOR | simvastatin | TABLET;ORAL | 019766-004 | Dec 23, 1991 | RE36481*PED | See Pricing |
| Msd Merck Co | ZOCOR | simvastatin | TABLET;ORAL | 019766-003 | Dec 23, 1991 | RE36520*PED | See Pricing |
| Msd Merck Co | ZOCOR | simvastatin | TABLET;ORAL | 019766-005 | Jul 10, 1998 | RE36520*PED | See Pricing |
| Msd Merck Co | EMEND | aprepitant | FOR SUSPENSION;ORAL | 207865-001 | Dec 17, 2015 | 6,096,742 | See Pricing |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for MSD MERCK CO drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Capsule | 40 mg, 80 mg and 125 mg | ➤ Subscribe | 2008-11-03 |
| ➤ Subscribe | Injection | 150 mg/vial | ➤ Subscribe | 2012-01-25 |
| ➤ Subscribe | Tablets | 10 mg | ➤ Subscribe | 2007-02-20 |
| ➤ Subscribe | Injection | 115 mg/vial | ➤ Subscribe | 2012-01-25 |
| ➤ Subscribe | for Oral Suspension | 125 mg/Kit | ➤ Subscribe | 2016-11-23 |
| ➤ Subscribe | Chewable Tablets | 4 mg and 5 mg | ➤ Subscribe | 2006-12-26 |
International Patents for Msd Merck Co Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Croatia | P20161680 | See Pricing |
| Croatia | P20040532 | See Pricing |
| Malaysia | 162532 | See Pricing |
| Argentina | 080859 | See Pricing |
| Peru | 01582013 | See Pricing |
| Australia | 2002360824 | See Pricing |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Msd Merck Co Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 2924034 | CA 2019 00024 | Denmark | See Pricing | PRODUCT NAME: DORAVIRINE, LAMIVUDINE AND DISOPROXIL; REG. NO/DATE: EU/1/18/1333 20181126 |
| 0734381 | PA2004002,C0734381 | Lithuania | See Pricing | PRODUCT NAME: 5-(((2R,3S)-2-((1R)-1-(3,5-BIS(TRIFLUORMETIL)FENIL)ETOKSI)-3-(4-FLUORFENIL)-4-MORFOLINIL)METIL)-1,2-DIHIDRO-3H-1,2,4-TRIAZOL-3-ONAS (APREPITANTAS); REGISTRATION NO/DATE: EU/1/03/262/001, 2003 11 11, EU/1/03/262/002, 2003 11 11, EU/1/03/262/003, 2003 11 11, EU/1/03/262/004, 2003 11 11, EU/1/03/262/005, 2003 11 11, EU/1/03/262/006 20031111 |
| 0480717 | 98C0022 | France | See Pricing | PRODUCT NAME: MONTELUKAST SODIUM; REGISTRATION NO/DATE IN FRANCE: NL 23 133 DU 19980320; REGISTRATION NO/DATE AT EEC: 13 651 DU 19970825 |
| 0734381 | 04C0010 | France | See Pricing | PRODUCT NAME: APREPITANT; REGISTRATION NO/DATE: EU/1/03/262/001 20031111 |
| 2552902 | 300980 | Netherlands | See Pricing | PRODUCT NAME: DORAVIRINE, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT; REGISTRATION NO/DATE: EU/1/18/1333/001-002 20181126 |
| 2552902 | CA 2019 00025 | Denmark | See Pricing | PRODUCT NAME: DORAVIRINE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF; REG. NO/DATE: EU/1/18/1333 20181126 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
